LOS ANGELES CAPITAL MANAGEMENT LLC
Position in EDIT — Editas Medicine, Inc.
CIK 1177206
LOS ANGELES, CA
Position in EDIT
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$346,857
+$146,361 QoQ
Shares Held
140,428
+43.6% QoQ
Ownership
0.143%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 33.35659555074486.ToString("F0")%
Shared 0.ToString("F0")%
None 66.64340444925514.ToString("F0")%
Common Shares in EDIT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026LOS ANGELES CAPITAL MANAGEMENT LLC holds $690,033,476 across 153 Biotechnology names. EDIT ranks #57 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
2,144,847 | $201,872,999 | |
| 2 | EXEL |
Exelixis, Inc.
|
3,102,634 | $133,071,972 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
78,880 | $60,945,843 | |
| 4 | RPRX |
Royalty Pharma plc
|
971,927 | $46,623,338 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
689,915 | $44,589,206 | |
| 6 | CAI |
Caris Life Sciences, Inc.
|
2,289,602 | $40,938,083 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
88,278 | $29,208,541 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
64,937 | $28,996,967 |
All Filings in EDIT
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $346,857 | 140,428 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $200,496 | 97,803 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $408,335 | 117,676 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $299,123 | 135,965 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $188,070 | 162,130 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $125,525 | 98,839 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $401,148 | 117,639 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $611,531 | 130,949 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $1,097,291 | 147,883 | Shares | Sole | 2024-04-05 | |
| 2022-09-30 | $446,184 | 36,453 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $426,660 | 36,066 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $606,528 | 31,889 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $428,623 | 16,144 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $670,055 | 16,311 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $923,855 | 16,311 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $850,542 | 20,251 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $2,723,913 | 38,852 | Shares | Sole | 2021-03-10 | |
| 2020-09-30 | $1,280,714 | 45,642 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $1,760,956 | 59,532 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $1,241,397 | 62,602 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||